Clinical Trial Update: Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy

View source ↗

Summary

A clinical trial investigating patient-derived cancer cell lines in untreated pancreatic ductal adenocarcinoma treated with gemcitabine-based chemotherapy has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Pancreatic Ductal Adenocarcinoma, Stage IA Pancreatic Cancer | Status: WITHDRAWN